Bringing new drugs to market requires biopharmaceutical companies to have strategies for discovering or obtaining potential drug candidates, advancing these candidates through the clinic and finally for commercialization. At Aderis, our multi-tiered business strategy encompasses each stage of this "candidate to product" evolution.
To learn more about the components in our novel business strategy, please click on any of the links in the diagram
"Our business strategy is rooted in the fact that maximum shareholder value and patient benefit is often obtained from both internally developed drugs and drugs in-licensed from others."
-Ken Rice,
Vice President and Chief Commercial Officer
